Get started
Author

Karlheinz Seeger

Prognostic value of minimal residual disease in relapsed childhood acute lymphoblastic leukaemia
2001 · Cornelia Eckert, Andrea Biondi, et al. · The Lancet · 214
TEL-AML1 Fusion Transcript in Relapsed Childhood Acute Lymphoblastic Leukemia
1998 · Karlheinz Seeger, Hans-Peter Adams, et al. · Blood · 174
Use of Allogeneic Hematopoietic Stem-Cell Transplantation Based on Minimal Residual Disease Response Improves Outcomes for Children With Relapsed Acute Lymphoblastic Leukemia in the Intermediate-Risk Group
2013 · Cornelia Eckert, Günter Henze, et al. · Journal of Clinical Oncology · 170
Mutations in the Nijmegen Breakage Syndrome gene (NBS1) in childhood acute lymphoblastic leukemia (ALL).
2001 · R Varon, A Reis, et al. · PubMed · 114
Activation of the HIF pathway in childhood ALL, prognostic implications of VEGF
2004 · S Wellmann, M Guschmann, et al. · Leukemia · 108
Specific Reverse Transcription-PCR Quantification of Vascular Endothelial Growth Factor (VEGF) Splice Variants by LightCycler Technology
2001 · Sven Wellmann, Tillmann Taube, et al. · Clinical Chemistry · 93
Minimal residual disease analysis by eight-color flow cytometry in relapsed childhood acute lymphoblastic leukemia
2015 · L. Karawajew, M. Dworzak, et al. · Haematologica · 81
PDF
High VLA-4 expression is associated with adverse outcome and distinct gene expression changes in childhood B-cell precursor acute lymphoblastic leukemia at first relapse
2011 · S. Shalapour, J. Hof, et al. · Haematologica · 78
PDF
Monitoring minimal residual disease in children with high-risk relapses of acute lymphoblastic leukemia: prognostic relevance of early and late assessment
2015 · C Eckert, N Hagedorn, et al. · Leukemia · 71
Advantages of a New Taq DNA Polymerase in Multiplex PCR and Time-Release PCR
1998 · C. Kebelmann-Betzing, K. Seeger, et al. · BioTechniques · 69
Potential of LightCycler technology for quantification of minimal residual disease in childhood acute lymphoblastic leukemia
2000 · C Eckert, O Landt, et al. · Leukemia · 66
Gene expression shift towards normal B cells, decreased proliferative capacity and distinct surface receptors characterize leukemic blasts persisting during induction therapy in childhood acute lymphoblastic leukemia
2007 · P Rhein, S Scheid, et al. · Leukemia · 48
Characterization of Cytokine, Growth Factor Receptor, Costimulatory and Adhesion Molecule Expression Patterns of Bone Marrow Blasts in Relapsed Childhood B Cell Precursor All
2001 · Christian Kebelmann-Betzing, Gabriele Körner, et al. · Cytokine · 47
FDG-PET in 10 children with Non-Hodgkin’s Lymphoma: Initial Experience in Staging and Follow-up
2005 · H. Amthauer, C. Furth, et al. · Klinische Pädiatrie · 44
EXPRESSION ANALYSIS AND CHARACTERIZATION OF ALTERNATIVELY SPLICED TRANSCRIPTS OF HUMAN IL-7Rα CHAIN ENCODING TWO TRUNCATED RECEPTOR PROTEINS IN RELAPSED CHILDHOOD ALL
2000 · Alexander Korte, Joachim Köchling, et al. · Cytokine · 35
Pediatric Colorectal Carcinoma is Associated With Excellent Outcome in the Context of Cancer Predisposition Syndromes
2015 · Marie L. Weber, Dominik T. Schneider, et al. · Pediatric Blood & Cancer · 34
Molecular quantification of response to therapy and remission status in TEL-AML1-positive childhood ALL by real-time reverse transcription polymerase chain reaction.
2001 · K Seeger, K A Kreuzer, et al. · PubMed · 32
TEL-AML1 Fusion in Relapsed Childhood Acute Lymphoblastic Leukemia
1999 · Karlheinz Seeger, Dirk Buchwald, et al. · Blood · 30
Extensive Alternative Splicing of Interleukin-7 in Malignant Hematopoietic Cells: Implication of Distinct Isoforms in Modulating IL-7 Activity
1999 · Alexander Korte, Anja Moricke, et al. · Journal of Interferon & Cytokine Research · 28
Rearrangements of T-cell receptor delta, gamma and beta genes in acute myeloid leukemia coexpressing T-lymphoid features.
1992 · C A Schmidt, H Oettle, et al. · PubMed · 27
Rituximab plus chemotherapy in children with relapsed or refractory CD20-positive B-cell precursor acute lymphoblastic leukemia.
2006 · Alexander Claviez, Cornelia Eckert, et al. · PubMed · 24
Comparison between TaqMan and LightCycler technologies for quantification of minimal residual disease by using immunoglobulin and T-cell receptor genes consensus probes
2003 · C Eckert, C A Scrideli, et al. · Leukemia · 24
Drug Cocktail Optimization in Chemotherapy of Cancer
2012 · Saskia Preissner, Mathias Dunkel, et al. · PLoS ONE · 20
PDF
Density and agonist‐promoted high and low affinity states of the β‐adrenoceptor on human B‐ and T‐cells
1988 · M. GRIESE, U. KÖRHOLZ, et al. · European Journal of Clinical Investigation · 20
Assessment of clonal stability of minimal residual disease targets between 1st and 2nd relapse of childhood precursor B-cell acute lymphoblastic leukemia.
2003 · Andreas Guggemos, Cornelia Eckert, et al. · PubMed · 19
Works count: 55
Citation count: 1,795
H-index: 22
I10-index: 29
Year
Topic
Type